The conflict between MSD Korea and its employees belonging to the outgoing GM (general medicine) division is intensifying.Last Friday, MSD Korea sent out another notice on its voluntary retirement program to all GM division employees.The email reportedly included a deadline of June 30 for submitting
AstraZeneca and SK Chemicals said they celebrated the production of the first diabetes combination drug batch (ingredient: dapagliflozin and sitagliptin) after the two companies initiated collaborative efforts in 2020.Under the accord, AstraZeneca will be responsible for domestic and global commerci
Huons said it has received marketing approval from the U.S. Food and Drug Administration (FDA) for a 2% lidocaine Inj. 5 mL Vial for local anesthesia. The approval comes after the company submitted the Abbreviated New Drug Application (ANDA) in December 2022. The FDA granted the approval because the
Hugel said it recently held a launch seminar for Licellvi (Korean name: Blue Rose Forte), a polydioxanone-based suture brand manufactured by J-World, Hugel's subsidiary, at the Pullman Bangkok Grande Sukhumvit Hotel in Thailand.To kick off the seminar, Kang Min-jong, Executive Director of Hugel's Sa
The Korea Exchange (KRX) announced on Thursday that it may designate SK Bioscience as an unfaithful disclosure corporation due to its failure to follow disclosure obligations.The stock market regulator said SK Bioscience disclosed its influenza vaccine supply contract worth about 25.8 billion won ($
Handok recently issued an apology to doctors and pharmacists after a personal information leak.Handok, on Friday, acknowledged that a hacking incident resulted in the leakage of some clients' information, as confirmed on June 2. The company stated, "Based on our current understanding, we believe tha
GSK's anti-PD-1 immunotherapy Jemperli (dostarlimab) has crossed the first threshold toward reimbursement six months after getting approval from the Ministry of Food and Drug Safety.Antengene's first-in-class XPO1 inhibitor Expovio (selinexor) became reimbursable as a fifth-line treatment for relaps
SK Biopharmaceuticals said that Health Canada granted a Notice of Compliance for Xcopri (ingredient: cenobamate), its epilepsy drug, approving its application for marketing authorization in Canada.Paladin Labs, a local pharmaceutical company, will be in charge of commercializing the product in Canad
Nomura Securities recently raised its price target for Medytox to 380,000 won ($298), a 44.8 percent increase from the previous target of 280,000 won, citing “optimism” for legal dispute settlement. However, industry watchers said the securities company failed to provide evidence to support such cla
Dong-A Pharmaceutical has joined with electroceutical developer Nu Eyne to enter the electroceutical business.Dong-A Pharm said it signed an exclusive domestic sales and supply agreement with Nu Eyne, a company specializing in the research and development of electroceuticals, for a migraine relief m
Daewoong Pharmaceutical said it obtained local marketing approval for Envlomet Sustained Release' (pipeline: DWJ1525), a combination drug mixing the domestic SGLT-2 inhibitor Envlo Tab. (ingredient: enavogliflozin) with metformin, a first-line treatment for diabetes.The Ministry of Food and Drug Saf
Geo-Young Corp., Korea's leading drug distributor, said the Fair Trade Commission (FTC) has given the go-ahead for the company to acquire a 25 percent stake in Baekje Pharmaceutical, the industry's runner-up drug distributor.With the acquisition of a stake in Baekje, industry watchers expect that Ge
JW Group said it has moved its headquarters to the JW Gwacheon Building, located in Gwacheon, Gyeonggi Province, to enhance research and development (R&D). The JW Gwacheon Building is based on a large-scale convergence research facility and holds all of the group's R&D personnel.The new building in
Daewoong Pharmaceutical and HanAll Biopharma said they will jointly invest in Vincere Biosciences, a Parkinson's disease drug development company based in Cambridge, Mass.With this investment, the three companies will explore opportunities to collaborate on the development of new treatments for Park
Kukje Pharm said Monday that it has signed an agreement with Eyegene to co-develop EG-Mirotin, the world's first treatment for non-proliferative diabetic retinopathy.According to Kukje, EG-Mirotin is a new-concept biological drug that treats diabetic retinopathy by relieving symptoms of recurrent sw
Bukwang Pharmaceutical has decided to withdraw its license for Fra-Cut Inj., a generic version of Mitsubishi Tanabe Pharma’s amyotrophic lateral sclerosis (ALS) treatment, Radicut (edaravone).That comes a year after the Ministry of Food and Drug Safety approved the drug.The ministry announced Monday
Hanmi Pharm said Monday its investigational drug, which failed to prove effectiveness in rheumatoid arthritis clinical trials, demonstrated efficacy against diffuse large B-cell lymphoma (DLBCL).The company said it disclosed the interim results from the phase 2 clinical trials of three-drug combinat
Minjuvi, a treatment for diffuse large B-cell lymphoma (DLBCL) imported by Handok, won marketing approval on Monday. The Ministry of Food and Drug Safety (MFDS) announced that it has approved Minjuvi (tafasitamab), an orphan drug used to treat DLBCL.DLBCL, one of the most common lymphomas, is a rapi
The five-month technology theft dispute between Algocare and Lotte over a nutrient dispenser product has reached an agreement, with Lotte Healthcare withdrawing the launch of the product.On Wednesday, the National Assembly held a meeting on the Prevention and Recovery Support for Start-up Technology
BOSTON, Mass. -- By Kim Chan-hyuk/Korea Biomedical Review correspondent -- A Korean pharmaceutical company has set its name engraved in Boston, Mass., a mecca for the global bio industry. The company is Yuhan USA, Yuhan Corp.’s U.S. offshoot. It is located within the Cambridge Innovation Center (CIC